Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DNL151 drug-drug interaction study with itraconazole in healthy volunteers
NL-OMON28697Active, not recruiting
- Sponsor
- Denali Therapeutics Inc.
- Start
- Oct 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of BIIB122 and itraconazole in Parkinson's disease (PD) (2 arms), sponsored by Denali Therapeutics Inc. Primary endpoints: Maximum plasma concentration of DNL151, Area under the concentration-time curve of DNL151 and 1 more. Started Oct 2018; status: active, not recruiting.
02
Drugs
BIIB122itraconazole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NL-OMON28697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28697.